Acetylcholinesterase inhibitors are frequently used in the treatment of Alzheimer disease due to their anti-inflammatory effects. But what is the potential of this class of medications to also impact the...
In this video, Alex Martinez discusses research on the use of human milk oligosaccharides (HMOs) in the prevention and treatment of nervous system diseases, such as Alzheimer disease, including the...
In this video, Paul Schulz, MD, discusses the next steps for research on the relationship between infection and Alzheimer disease. This is part three in a three-part series.
In this episode, Ryan Maddox, PhD, discusses his team's study on the incidence of prion disease in the United States from 2003 to 2015, and also examines the topic in the context of his prior research in...
In this 1-minute video, Wendy Wright, DNP, recaps her presentation on diagnosing and treating dizziness and vertigo from the 2020 Practical Updates in Primary Care virtual series.
David Holtzman, MD, talks about the established biomarkers for Alzheimer disease, potential biomarkers being investigated, and how long it may take for these biomarker tests to make it to the bedside.
With the current spike in US cases of acute flaccid myelitis in mind, Matthew J. Elrick, MD, PhD, from the Johns Hopkins School of Medicine, reviews clinical manifestations, diagnosis, and treatment for the...
Ilya Kister, MD, from NYU Langone Health in New York City, discusses his research into the predictors of multiple sclerosis relapse and disability progression in patients who stop disease-modifying...
Ajay Verma, MD, PhD, Vice President, Translational Neurology, Biogen Inc., assesses the neurodegeneration problem that will accompany the significant increase in the elderly population. He discusses...
